As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Proteasome Inhibitors Market: By Product: Velcade, Kyprolis, Ninlaro, Others; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; SWOT Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments

Global Proteasome Inhibitors Market Outlook

The global proteasome inhibitors market is expected to grow at a CAGR of 8.4% in the forecast period of 2021-2026 to reach nearly USD 2.3 billion by 2026.

 

Global Proteasome Inhibitors Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The industry is expanding due to the development in the research sector, providing treatment for multiple myeloma and drugs to treat pancreatic cancer. North America held the largest market share in 2018, however, it is anticipated to witness a slower growth during the forecast period because of the rising number of substitutes approved by the government, especially in the United States.

 

Properties and Applications

Proteasome inhibitors help in the prevention or delay in the degradation of proapoptotic factors. It facilitates the programmed cell death that ultimately cures the disease. The various product types of proteasome inhibitors are:

 

Global Proteasome Inhibitors Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Velcade
  • Kyprolis
  • Ninlaro
  • Others

The EMR report looks into the regional proteasome inhibitors markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Proteasome Inhibitors Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The global proteasome inhibitors market is being driven by the enormous unmet demand and expanding applications of proteasome inhibitors in the treatment of blood cancer and primarily myeloma. The industry is further aided by the rising prevalence of cancer, globally, as proteasome has proved to be efficient for treating cancer indications. The ability of the drug is prompting vendors to conduct studies on the therapeutics effects of the product on solid tumours, hence, promoting the growth of the industry. The other factor leading to the growth of the proteasome inhibitors market is the application of proteasome inhibitors in the treatment of various health conditions. North America accounted for the largest industry share in 2018 due to the high incidences of multiple myeloma and non-Hodgkin’s lymphoma in the region. However, Europe and Asia, are expected to witness a significant growth during the forecast period owing to increased incidences of myeloma and rising sales of proteasome inhibitors in the regions.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global proteasome inhibitors market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Allergan Plc (NYSE: AGN)
  • Amgen Inc. (NASDAQ: AMGN)
  • Celgene Corp. (NASDAQ: CELG)
  • Johnson & Johnson Services Inc. (NYSE: JNJ)
  • Takeda Pharmaceutical Co. Ltd. (TYO: 4502)
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.

 

Key Questions Answered in the Report

  • How has the global proteasome inhibitors market performed in the previous years (2016-2020)?
  • What is the forecast assessment of the global proteasome inhibitors market for 2021-2026?
  • What are the major drivers for the historical (2016-2020) & Forecast (2021-2026)?
  • What are the major constraints for the historical (2016-2020) & Forecast (2021-2026) periods?
  • What are the major demand indicators of the global industry?
  • Who are the key manufacturers of velcade, kyprolis, ninlaro, and others in the global industry?
  • What is the degree of competition in the global industry?
  • What are the major events and developments taking place within the industry, globally?

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraint Analysis
    5.3    Industry Challenges
    5.4    Industry Opportunities
6    Global Proteasome Inhibitors Market Analysis
    6.1    Global Proteasome Inhibitors Historical Market (2016-2020) & Forecast (2021-2026)
    6.2    Global Proteasome Inhibitors Market Breakup by Product
        6.2.1    Velcade
        6.2.2    Kyprolis
        6.2.3    Ninlaro
        6.2.4    Others
    6.3    Global Proteasome Inhibitors Market Breakup by Product: Historical Market (2016-2020) & Forecast (2021-2026)
        6.3.1    Velcade
        6.3.2    Kyprolis
        6.3.3    Ninlaro
        6.3.4    Others
    6.4    Global Proteasome Inhibitors Market Breakup by Region
        6.4.1    North America
            6.4.1.1    United States of America
            6.4.1.2    Canada
        6.4.2    Europe
            6.4.2.1    Germany
            6.4.2.2    United Kingdom
            6.4.2.3    France
            6.4.2.4    Italy
            6.4.2.5    Others
        6.4.3    Asia Pacific
            6.4.3.1    China
            6.4.3.2    Japan
            6.4.3.3    India
            6.4.3.4    ASEAN
            6.4.3.5    Others
        6.4.4    Latin America
            6.4.4.1    Brazil
            6.4.4.2    Argentina
            6.4.4.3    Mexico
            6.4.4.4    Others
        6.4.5    Middle East & Africa
            6.4.5.1    Saudi Arabia
            6.4.5.2    United Arab Emirates
            6.4.5.3    Nigeria
            6.4.5.4    South Africa
            6.4.5.5    Others
    6.5     Global Proteasome Inhibitors Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
        6.5.1    North America
            6.5.1.1    United States of America
            6.5.1.2    Canada
        6.5.2    Europe
            6.5.2.1    Germany
            6.5.2.2    United Kingdom
            6.5.2.3    France
            6.5.2.4    Italy
            6.5.2.5    Others
        6.5.3    Asia Pacific
            6.5.3.1    China
            6.5.3.2    Japan
            6.5.3.3    India
            6.5.3.4    ASEAN
            6.5.3.5    Others
        6.5.4    Latin America
            6.5.4.1    Brazil
            6.5.4.2    Argentina
            6.5.4.3    Mexico
            6.5.4.4    Others
        6.5.5    Middle East & Africa
            6.5.5.1    Saudi Arabia
            6.5.5.2    United Arab Emirates
            6.5.5.3    Nigeria
            6.5.5.4    South Africa
            6.5.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    Competitive Landscape & Supplier Analysis  
    9.1    Allergan Plc (NYSE: AGN)
        9.1.1    Company Overview
        9.1.2    Financial Analysis 
    9.2    Amgen Inc. (NASDAQ: AMGN)
        9.2.1    Company Overview
        9.2.2    Financial Analysis 
    9.3    Celgene Corp. (NASDAQ: CELG)
        9.3.1    Company Overview
        9.3.2    Financial Analysis 
    9.4    Johnson & Johnson Services Inc. (NYSE: JNJ)
        9.4.1    Company Overview
        9.4.2    Financial Analysis 
    9.5    Takeda Pharmaceutical Co. Ltd. (TYO: 4502)
        9.5.1    Company Overview
        9.5.2    Financial Analysis 
    9.6    Others
10    Industry Events and Developments

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

United States Compounding Pharmacies Market Report and Forecast 2021-2026


Global Anaesthesia Drugs Market Report and Forecast 2021-2026


United States HIV Drugs Market Report and Forecast 2021-2026


Global Parkinson’s Disease Drugs Market Report and Forecast 2021-2026


Global Nootropics Market Report and Forecast 2021-2026


NEWSLETTER